STELLAR-Rosuvastatin vs. Atorvastatin, Pravastatin, Simvastatin across dose ranges - STELLAR

Study identifier:4522IL/0065

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A 6 week Open Label, Dose Comparison Study to Evaluate the Safety and Efficacy of Rosuvastatin versus Atorvastatin, Pravastatin, and Simvastatin in subjects with Hypercholesterolemia.

Medical condition

Hypercholesterolemia

Phase

Phase 3

Healthy volunteers

No

Study drug

Rosuvastatin, Atorvastatin, Pravastatin, Simvastatin

Sex

All

Actual Enrollment

5625

Study type

Interventional

Age

18 Years +

Date

Study Start Date: 01 Apr 2001
Primary Completion Date: -
Study Completion Date: 01 Oct 2004

Study design

Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment

Verification:

Verified 01 Dec 2013 by AstraZeneca Pharmaceuticals

Sponsors

AstraZeneca Pharmaceuticals

Collaborators

-

Inclusion and exclusion criteria